We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
-11.84%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$55.1M
AUM Growth
+$21.2M
(+62%)
Cap. Flow
+$7.38M
Cap. Flow
% of AUM
13.39%
Top 10 Holdings %
Top 10 Hldgs %
86.36%
Holding
70
New
24
Increased
1
Reduced
17
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PLRZ
Polyrizon Ltd
PLRZ
|
+$17.5M |
| 2 |
KUST
Kustom Entertainment Inc
KUST
|
+$2.05M |
| 3 |
Tempest Therapeutics
TPST
|
+$1.97M |
| 4 |
Lexaria Bioscience
LEXX
|
+$1.34M |
| 5 |
SUNE
SUNation Energy
SUNE
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Surf Air Mobility
SRFM
|
+$4.72M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.85M |
| 3 |
Eli Lilly
LLY
|
+$2.82M |
| 4 |
Eos Energy Enterprises
EOSE
|
+$1.68M |
| 5 |
Knightscope
KSCP
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.99% |
| 2 | Industrials | 4.72% |
| 3 | Financials | 1.4% |
| 4 | Consumer Discretionary | 0.84% |
| 5 | Technology | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bluejay Diagnostics
BJDX
$1.07M
| $165K | 0.3% |
+24,008
| New | +$196K |
|
27
reAlpha
AIRE
$7.4M
| $160K | 0.29% |
+20,938
| New | +$299K |
|
|
28
CALL
Eos Energy Enterprises
EOSE
$1.23B
| $126K | 0.23% |
+246
| New | +$1.21K |
|
|
BNBX
29
DELISTED
BNB PLUS CORP
BNBX
| $125K | 0.23% |
+24,355
| New | +$259K |
|
30
Vivani Medical
VANI
$110M
| $121K | 0.22% |
93,825
-757,782
| -89% | -$835K |
|
|
BCTX
31
Briacell Therapeutics
BCTX
$31.1M
| $116K | 0.21% |
+3,953
| New | +$144K |
|
|
EMPD
32
Empery Digital
EMPD
$94.2M
| $110K | 0.2% |
15,835
-10,582
| -40% | -$61.7K |
|
33
Psyence Biomedical
PBM
$11.3M
| $108K | 0.2% |
3,252
-1,901
| -37% | -$52.6K |
|
34
PUT
Zevra Therapeutics
ZVRA
$563M
| $93.4K | 0.17% |
106
-650
| -86% | -$5.28K |
|
|
RVPH
35
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $64.8K | 0.12% |
+8,496
| New | +$132K |
|
36
Revelation Biosciences
REVB
$4.14M
| $49.3K | 0.09% |
+5,482
| New | +$143K |
|
37
SunCar Technology Group
SDA
$77M
| $46.4K | 0.08% |
18,200
| – | – |
|
38
Acurx Pharmaceuticals
ACXP
$6.1M
| $41.8K | 0.08% |
4,095
-98,132
| -96% | -$790K |
|
39
Nuwellis
NUWE
$189K
| $32.6K | 0.06% |
+101
| New | +$112K |
|
|
UCAR
40
U Power Ltd
UCAR
$24.4M
| $22.8K | 0.04% |
594
-6,624
| -92% | -$202K |
|
41
Elevai Labs
ELAB
$4.09M
| $11.5K | 0.02% |
63
-395
| -86% | -$85.4K |
|
|
RVPH
42
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $10.1K | 0.02% |
13
-671
| -98% | -$10.4K |
|
|
SBFM
43
Sunshine Biopharma
SBFM
$3.53M
| $2.24K | ﹤0.01% |
+156
| New | +$2.28K |
|
44
AEON Biopharma
AEON
$11.1M
| – | – |
-449,687
| Closed | -$261K |
|
45
AGM Group Holdings
AGMH
$2.53M
| – | – |
-3,114
| Closed | -$7.26K |
|
|
ALUR
46
DELISTED
Allurion Technologies
ALUR
| – | – |
-27,890
| Closed | -$89.5K |
|
|
CKPT
47
PUT
DELISTED
Checkpoint Therapeutics
CKPT
| – | – |
-354
| Closed | -$24.6K |
|
48
Core Scientific
CORZ
$7.23B
| – | – |
-60,000
| Closed | -$600K |
|
49
Cyngn
CYN
$15.6M
| – | – |
-160,000
| Closed | -$725K |
|
50
Ensysce Biosciences
ENSC
$4.02M
| – | – |
-46,954
| Closed | -$120K |
|
Similar funds
NA
CG
OC
ICCON
PCM
CAS
CM
MCMC
Sabby Management's Q2 2025 Portfolio in Review
As of Q2 2025, Sabby Management held 70 positions worth $55.1M, up 62% from $34M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Sabby Management deployed $7.38M of net new capital in Q2 2025, opening 24 new positions and adding to 1 existing holding. Its largest new stake was Polyrizon Ltd: 56,744 shares worth $252K.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $3.85M trimmed.
- Sabby Management's largest Q2 2025 buy was Polyrizon Ltd: 56,744 shares worth $252K.
- Sabby Management added most to Frontier Nuclear and Minerals Inc in Q2 2025, an estimated $139K increase.
- Sabby Management's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $3.85M.
- Sabby Management fully exited Surf Air Mobility in Q2 2025, selling an estimated $4.72M.
- Sabby Management's ten largest holdings make up 86% of its $55.1M portfolio in Q2 2025.
- Sabby Management opened 24 new positions and closed 27 in Q2 2025.
- Sabby Management's portfolio value rose 62% quarter-over-quarter to $55.1M.
Based on Sabby Management's 13F filing for Q2 2025, filed 14 Aug 2025.